The RGLG1 antibody is a laboratory-generated reagent designed to detect and study the RGLG1 protein in Arabidopsis thaliana and other plants. RGLG1 is a RING-type E3 ubiquitin ligase that regulates protein homeostasis through ubiquitination, impacting immune signaling and abscisic acid (ABA)-mediated stress responses .
RGLG1 antibodies are instrumental in:
Co-immunoprecipitation (Co-IP) assays: Identifying protein-protein interactions, such as RGLG1’s association with BIK1 (a kinase central to plant immunity) .
Western blotting: Detecting RGLG1 expression levels under different conditions (e.g., pathogen exposure or ABA treatment) .
Functional studies: Validating genetic mutants (e.g., rglg1 rglg2 double mutants) to assess immune signaling defects .
BIK1 Regulation: RGLG1 forms a complex with BIK1 and its co-receptor BAK1, enhancing immune signaling by preventing BIK1 degradation .
Cross-Regulation with PUB25: RGLG1/2 suppress the ubiquitin ligase activity of PUB25, creating a feedback loop to maintain BIK1 protein levels .
ABA Signaling: RGLG1 mediates ABA-induced degradation of PP2CA, relieving inhibition of ABA-responsive kinases .
Co-IP Assays: Anti-RGLG1 antibodies confirmed reduced association between RGLG1 and BIK1 upon flg22 treatment, linking phosphorylation status to immune activation .
Mutant Analysis: rglg1 rglg2 mutants exhibited compromised pathogen resistance and ABA hypersensitivity, underscoring RGLG1’s dual regulatory roles .
Antibody Specificity: Current antibodies (e.g., anti-FLAG/HA tags) require validation for endogenous RGLG1 detection in non-transgenic systems.
Therapeutic Potential: While RGLG1 is plant-specific, insights into ubiquitin ligase regulation could inform engineered antibody-ligase systems (e.g., PROTABs) in mammals .